Product information
From Health Canada
The product monograph is developed by a drug sponsor according to guidelines published by Health Canada that provide direction on the content and format. The veterinary labelling is developed by the drug sponsor according to the Food and Drug Regulations. While Health Canada reviews the product monograph or the veterinary labelling as part of the drug review process, it remains the responsibility of the drug sponsor to ensure that the product monograph or the veterinary labelling is complete and accurate.
Current status:
Marketed
Current status date:
2019-08-23
Original market date: See footnote 1
2014-09-11
Product name:
ASCOR L 500
Description:
ASCORBIC ACID INJECTION
DIN:
02355981
Product Monograph/Veterinary Labelling:
Date:
2010-09-08
Product monograph/Veterinary Labelling (PDF version ~ 175K)
Company:
MCGUFF PHARMACEUTICALS INC
141
2921 W. Macarthur Blvd
Santa Ana
California
United States
92704
Class:
Human
Dosage form(s):
Solution
Route(s) of administration:
Intramuscular , Intravenous , Subcutaneous
Number of active ingredient(s):
1
Schedule(s):
Ethical
American Hospital Formulary Service (AHFS): See footnote 3
88:12.00
Anatomical Therapeutic Chemical (ATC): See footnote 4
A11GA01 ASCORBIC ACID (VIT C)
Active ingredient group (AIG) number:See footnote5
0108469006
| Active ingredient(s) | Strength |
|---|---|
| ASCORBIC ACID | 500 MG / ML |